GCIA
AVDL

Gabelli & Co Investment Advisers’s Avadel Pharmaceuticals AVDL Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-297,566
Closed -$6.41M – 304
2025
Q4 		$6.41M Buy
+297,566
New +$5.78M 0.96% 28

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli & Co Investment Advisers's AVDL Position: Q1 2026 in Review

Gabelli & Co Investment Advisers sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 297,566 shares — an estimated $6.41M sold.

Gabelli & Co Investment Advisers first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $6.41M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Gabelli & Co Investment Advisers reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 297,566 Avadel Pharmaceuticals shares in Q1 2026, an estimated $6.41M.
  • Gabelli & Co Investment Advisers first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Avadel Pharmaceuticals position peaked at $6.41M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.